Spinal muscular atrophy: Gene therapy approved by NHS

Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation at Nice, said: “Spinal Muscular Atrophy is a very serious, debilitating and distressing condition that has very significant effects on every aspect of life of those with SMA, and their families and carers.

More Stories
At least six people are injured after suspect stabs victims at Vancouver library